September 24, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Immunovant, Inc. (“Immunovant” or “the Company”) (NASDAQ: IMVT). Investors who purchased Immunovant securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Immunovant… read more
September 22, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Endava plc (“Endava” or “the Company”) (NYSE: DAVA). Investors who purchased Endava securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Endava… read more
September 21, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BellRing Brands, Inc. (“BellRing” or “the Company”) (NYSE: BRBR). Investors who purchased BellRing securities prior to November 19, 2024, and continue to hold to the present, are encouraged… read more
September 20, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TESTLIVETEMPLATENEW2 (“TESTLIVETEMPLATENEW2” or “the Company”) (NASDAQ: TESTLIVETEMPLATENEW2). Investors who purchased TESTLIVETEMPLATENEW2 securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TESTLIVETEMPLATENEW2 has… read more
September 18, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of J.B. Hunt Transport Services, Inc. (“J.B. Hunt” or “the Company”) (NASDAQ: JBHT). Investors who purchased J.B. Hunt securities are encouraged to obtain additional information and assist the investigation…. read more
September 18, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cellebrite DI Ltd. (“Cellebrite” or “the Company”) (NASDAQ: CLBT). Investors who purchased Cellebrite securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 18, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Astrana Health, Inc. (“Astrana” or “the Company”) (NASDAQ: ASTH). Investors who purchased Astrana securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 18, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jackson Financial Inc. (“Jackson Financial” or “the Company”) (NYSE: JXN). Investors who purchased Jackson Financial securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
September 18, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fluence Energy, Inc. (“Fluence” or “the Company”) (NASDAQ: FLNC). Investors who purchased Fluence securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 18, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Corning Incorporated (“Corning” or “the Company”) (NYSE: GLW). Investors who purchased Corning securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Corning… read more
September 16, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating the announced buyout of The Baldwin Group, Inc. (“Baldwin”) (NASDAQ: BWIN) by Sequence Holdings and DFO Management. Investors who purchased Baldwin and continue to hold to the present are encouraged to obtain additional information and… read more
September 16, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cellectis S.A. (“Cellectis” or “the Company”) (NASDAQ: CLLS). Investors who purchased Cellectis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cellectis… read more
September 16, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SolarEdge Technologies, Inc. (“SolarEdge” or “the Company”) (NASDAQ: SEDG). Investors who purchased SolarEdge securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 16, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Planet Fitness, Inc. (“Planet Fitness” or “the Company”) (NYSE: PLNT). Investors who purchased Planet Fitness securities prior to November 6, 2025, and continue to hold to the present,… read more
September 16, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GPGI, Inc. f/k/a CompoSecure, Inc. (“GPGI” or “the Company”) (NYSE: GPGI). Investors who purchased GPGI securities prior to November 3, 2025, and continue to hold to the present,… read more
September 16, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Enova International, Inc. (“Enova” or “the Company”) (NYSE: ENVA). Investors who purchased Enova securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 14, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Photronics, Inc. (“Photronics” or “the Company”) (NASDAQ: PLAB). Investors who purchased Photronics securities prior to December 10, 2025, and continue to hold to the present, are encouraged to… read more
September 14, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tyra Biosciences, Inc. (“Tyra” or “the Company”) (NASDAQ: TYRA). Investors who purchased Tyra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 10, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Cooper Companies, Inc. (“Cooper Companies” or “the Company”) (NASDAQ: COO). Investors who purchased Cooper Companies securities are encouraged to obtain additional information and assist the investigation. The… read more
September 10, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novartis AG (“Novartis” or “the Company”) (NYSE: NVS). Investors who purchased Novartis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Novartis… read more
September 10, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of La-Z-Boy Incorporated (“La-Z-Boy” or “the Company”) (NYSE: LZB). Investors who purchased La-Z-Boy securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether La-Z-Boy… read more
September 10, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EyePoint, Inc. (“EyePoint” or “the Company”) (NASDAQ: EYPT). Investors who purchased EyePoint securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether EyePoint… read more
September 9, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ServiceTitan, Inc. (“ServiceTitan” or “the Company”) (NASDAQ: TTAN). Investors who purchased ServiceTitan securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ServiceTitan… read more
September 9, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stryker Corporation (“Stryker” or “the Company”) (NASDAQ: SYK). Investors who purchased Stryker securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Stryker… read more
September 8, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or “the Company”) (NASDAQ: RARE). Investors who purchased Ultragenyx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 8, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of lululemon athletica inc. (“lululemon” or “the Company”) (NASDAQ: LULU). Investors who purchased lululemon securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tyson Foods, Inc. (“Tyson Foods” or “the Company”) (NYSE: TSN). Investors who purchased Tyson Foods securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
September 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Guggenheim Strategic Opportunities Fund (“Guggenheim” or “the Company”) (NYSE: GOF). Investors who purchased Guggenheim securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
September 2, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insulet Corporation (“Insulet Corporation” or “the Company”) (NASDAQ: PODD). Investors who purchased Insulet Corporation securities prior to May 21, 2026, and continue to hold to the present, are… read more
September 2, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. (“D-Wave” or “the Company”) (NASDAQ: QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more